![]() PMV Pharma PMV Pharma is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus. | ||
Founding Date | Founding Date 2013 | Founding Date 2012 |
Type | Type Public | Type Private |
Tags | ||
Locations | Locations Cranbury Township, US HQ | Locations Cambridge, US HQ |
Employees | Employees 642% increase | Employees 244% decrease |
Funding | ||
Total funding raised | Total funding raised $ 236m | Total funding raised $ 36m |

Portal Instruments is a development stage, venture-backed company
View company